Dunn Edmund
Principal Accounting Officer · 6 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 139 | $17.96 | $2,496.44 | filing |
| 2026-03-02 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 536 | $17.50 | $9,380.00 | filing |
| 2026-03-02 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 536 | $13.41 | $7,187.76 | filing |
| 2026-02-27 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 25,164 | $18.10 | $455,506.15 | filing |
| 2026-02-27 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 25,164 | $13.41 | $337,449.24 | filing |
| 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 1,039 | $15.17 | $15,761.63 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.